An ethogram analysis of cutaneous thermal pain sensitivity and oxycodone reward-related behaviors in rats.


Journal

Research square
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035

Informations de publication

Date de publication:
24 Mar 2023
Historique:
medline: 31 3 2023
entrez: 30 3 2023
pubmed: 31 3 2023
Statut: epublish

Résumé

Inter-relationships between pain sensitivity, drug reward, and drug misuse are of considerable interest given that many analgesics exhibit misuse potential. Here we studied rats as they underwent a series of pain- and reward-related tests: cutaneous thermal reflex pain, induction and extinction of conditioned place preference to oxycodone (0.56 mg/kg), and finally the impact of neuropathic pain on reflex pain and reinstatement of conditioned place preference. Oxycodone induced a significant conditioned place preference that was extinguished throughout repeated testing. Correlations identified of particular interest included an association between reflex pain and oxycodone-induced behavioral sensitization, and between rates of behavioral sensitization and extinction of conditioned place preference. Multidimensional scaling analysis followed by k-clustering identified three clusters: (1) reflex pain and the rate of change in reflex pain response throughout repeated testing, (2) basal locomotion, locomotor habituation, and acute oxycodone-stimulated locomotion, and (3) behavioral sensitization, strength of conditioned place preference, and rate of extinction. Nerve constriction injury markedly enhanced reflex pain but did not reinstate conditioned place preference. These results support the notion that behavioral sensitization relates to the acquisition and extinction of oxycodone seeking/reward, but suggest that generally cutaneous thermal reflex pain poorly predicts oxycodone reward-related behaviors except for behavioral sensitization.

Identifiants

pubmed: 36993634
doi: 10.21203/rs.3.rs-2679319/v1
pmc: PMC10055647
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA046411
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA049470
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

Rev Pain. 2010 Mar;4(1):8-12
pubmed: 26527193
Cannabis Cannabinoid Res. 2022 Dec;7(6):804-813
pubmed: 34962133
Addict Biol. 2014 Jul;19(4):552-61
pubmed: 23231598
Pain Physician. 2010 Sep-Oct;13(5):401-35
pubmed: 20859312
Pharmacol Biochem Behav. 2012 Jan;100(3):370-6
pubmed: 21807020
Annu Rev Med. 2018 Jan 29;69:451-465
pubmed: 29029586
Am J Med Genet B Neuropsychiatr Genet. 2003 Aug 15;121B(1):76-82
pubmed: 12898579
Alcohol. 2015 Dec;49(8):803-9
pubmed: 26008713
Pain Physician. 2008 Mar;11(2 Suppl):S63-88
pubmed: 18443641
Eur J Pharmacol. 2009 Jan 14;602(2-3):321-7
pubmed: 19071107
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87(Pt B):263-268
pubmed: 28501595
Neuropharmacology. 2020 May 1;167:107978
pubmed: 32001238
Pain. 2021 Nov 1;162(11):2737-2749
pubmed: 33902092
J Pain Symptom Manage. 1994 Oct;9(7):462-73
pubmed: 7822886
J Vis Exp. 2018 Nov 6;(141):
pubmed: 30474645
Neuron. 2016 Jan 6;89(1):11-36
pubmed: 26748087
J Neurosci. 2015 Feb 25;35(8):3689-700
pubmed: 25716866
Neural Plast. 2017;2017:9724371
pubmed: 28706741
Brain Res Rev. 2009 Mar;59(2):253-77
pubmed: 18762212
Neuropsychopharmacology. 2016 Jan;41(1):335-56
pubmed: 25976297
Behav Brain Res. 2005 May 7;160(1):34-43
pubmed: 15836898
Pharmacol Biochem Behav. 2016 Sep;148:99-105
pubmed: 27316549
Neuropharmacology. 2020 May 1;167:107864
pubmed: 31778689
J Neurochem. 2002 Sep;82(5):1192-8
pubmed: 12358766
Neuropharmacology. 2019 Dec 1;160:107778
pubmed: 31526808
Neurosci Biobehav Rev. 2022 Aug;139:104744
pubmed: 35716877
Psychopharmacology (Berl). 2021 Jul;238(7):1885-1897
pubmed: 33765177
Nat Neurosci. 2014 Oct;17(10):1304-12
pubmed: 25254980
Pharmacol Biochem Behav. 2013 Sep;110:112-6
pubmed: 23827650
Eur J Neurosci. 2009 Mar;29(5):1015-26
pubmed: 19245370
Neuropharmacology. 2021 Mar 15;186:108476
pubmed: 33524407
Psychopharmacology (Berl). 2020 May;237(5):1545-1555
pubmed: 32114633
Br J Soc Clin Psychol. 1965 Sep;4(3):224-9
pubmed: 5872680
Addict Biol. 2023 Jan;28(1):e13253
pubmed: 36577735
Nat Rev Neurosci. 2008 Apr;9(4):314-20
pubmed: 18354400
Neuropharmacology. 2022 Mar 1;205:108925
pubmed: 34921830
Crit Rev Toxicol. 2008;38(7):599-617
pubmed: 18709568
Neurosci Lett. 2019 Nov 20;713:134514
pubmed: 31560995
Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):13107-13115
pubmed: 31182603
Curr Opin Pharmacol. 2005 Feb;5(1):9-19
pubmed: 15661620
Science. 1989 Sep 29;245(4925):1511-3
pubmed: 2781295
Behav Pharmacol. 2022 Sep 1;33(6):418-426
pubmed: 35947068
Eur J Neurosci. 2014 Oct;40(7):3041-3054
pubmed: 25208732
J Basic Clin Pharm. 2016 Mar;7(2):27-31
pubmed: 27057123
Neuropharmacology. 2016 Dec;111:314-322
pubmed: 27614221
Front Behav Neurosci. 2020 Sep 29;14:582147
pubmed: 33132862
Acta Pharmacol Sin. 2005 May;26(5):533-8
pubmed: 15842769
Addict Biol. 2022 Mar;27(2):e13148
pubmed: 35229934
Neuropharmacology. 2020 Dec 15;181:108351
pubmed: 33031806
Neuroscience. 2018 Nov 21;393:236-257
pubmed: 30316908
Neuropsychopharmacology. 2014 Aug;39(9):2263-71
pubmed: 24686896
Brain Res. 1999 Sep 18;842(1):200-5
pubmed: 10526110
Pain. 1994 Sep;58(3):355-366
pubmed: 7838585
Exp Clin Psychopharmacol. 2008 Oct;16(5):357-66
pubmed: 18837632
Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
pubmed: 8401595
Synapse. 2019 May;73(5):e22088
pubmed: 30632204
Wiley Interdiscip Rev Cogn Sci. 2013 Jan;4(1):93-103
pubmed: 23359318
J Comp Neurol. 2016 Jun 1;524(8):1646-52
pubmed: 26788716
Psychol Rev. 1987 Oct;94(4):469-92
pubmed: 3317472
Neurosci Lett. 2013 Dec 17;557 Pt A:60-4
pubmed: 23973302
Pharmacol Rev. 2011 Jun;63(2):348-65
pubmed: 21490129
Neuropharmacology. 2014 Jan;76 Pt B:425-36
pubmed: 23639434
Curr Top Behav Neurosci. 2013;13:403-32
pubmed: 22389178

Auteurs

Ariana C Brice-Tutt (AC)

Departments of Orthodontics, University of Florida, Gainesville, Florida, USA.

Darrice S Montgomery (DS)

Departments of Orthodontics, University of Florida, Gainesville, Florida, USA.

Cassidy M Kramer (CM)

Departments of Orthodontics, University of Florida, Gainesville, Florida, USA.

Peter M Novotny (PM)

Departments of Orthodontics, University of Florida, Gainesville, Florida, USA.

Wendi L Malphurs (WL)

Departments of Orthodontics, University of Florida, Gainesville, Florida, USA.

Abhisheak Sharma (A)

Department of Pharmaceutics, University of Florida, Gainesville, Florida, USA.

Robert M Caudle (RM)

Department of Oral and Maxillofacial Surgery, University of Florida, Gainesville, Florida, USA.

Adriaan W Bruijnzeel (AW)

Department of Psychiatry, University of Florida, Gainesville, Florida, USA.
Center for Addiction Research and Education, University of Florida, Gainesville, Florida, USA.

Barry Setlow (B)

Department of Psychiatry, University of Florida, Gainesville, Florida, USA.
Center for Addiction Research and Education, University of Florida, Gainesville, Florida, USA.

John K Neubert (JK)

Departments of Orthodontics, University of Florida, Gainesville, Florida, USA.

Niall P Murphy (NP)

Departments of Orthodontics, University of Florida, Gainesville, Florida, USA.

Classifications MeSH